Literature DB >> 2871866

L-pipecolaturia in Zellweger syndrome.

S Lam, J Hutzler, J Dancis.   

Abstract

Purified rat peroxisomes have been reported to oxidize D-pipecolic acid and the pipecolaturia of Zellweger syndrome has been attributed to the absence of peroxisomes. The logical consequences would be excesses of D-pipecolic acid in the urine of patients with Zellweger syndrome. The urine of two patients with Zellweger syndrome has been analyzed by complexing the pipecolic acid to copper-aspartame to separate the L- and D-isomers. L-Pipecolic acid constituted 100% and 78% of the total pipecolic acid in the two urines. The possibility of preferential retention of D-pipecolic acid was excluded by measuring renal excretion in two control subjects following administration of each isomer. The clearance of L-pipecolic acid was 1.1 and 0.2 ml/min and of D-pipecolic acid was 36.4 and 43.6 ml/min. These results do not support the contention that the pipecolaturia of Zellweger syndrome is the direct result of peroxisomal deficiencies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871866     DOI: 10.1016/0304-4165(86)90162-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Osmoprotection by pipecolic acid in Sinorhizobium meliloti: specific effects of D and L isomers.

Authors:  K Gouffi; T Bernard; C Blanco
Journal:  Appl Environ Microbiol       Date:  2000-06       Impact factor: 4.792

2.  Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus.

Authors:  Andrew D Patterson; Jessica A Bonzo; Fei Li; Kristopher W Krausz; Gabriel S Eichler; Sadaf Aslam; Xenia Tigno; John N Weinstein; Barbara C Hansen; Jeffrey R Idle; Frank J Gonzalez
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

3.  Species variation in organellar location and activity of L-pipecolic acid oxidation in mammals.

Authors:  S J Mihalik; W J Rhead
Journal:  J Comp Physiol B       Date:  1991       Impact factor: 2.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.